| 000 | 03369nam a22003014a 4500 | ||
|---|---|---|---|
| 005 | 20250914145401.0 | ||
| 008 | 060710s2005 ne a b 001 0 eng | ||
| 020 |
_a0127389032 (alk. paper) _cRM462.50 |
||
| 039 | 9 |
_a200611140900 _bwmeriam _c200607201610 _dzainol _c200607201606 _dzainol _y07-10-2006 _zrazalis |
|
| 060 |
_aWL140 _b.F931 2005 9 |
||
| 090 | _aWL140.F931 2005 9 | ||
| 245 | 0 | 0 |
_aFrom neuroscience to neurology : _bneuroscience, molecular medicine, and the therapeutic transformation of neurology / _cedited by Stephen Waxman |
| 260 |
_aAmsterdam : _bElsevier Academic Press, _c2005 |
||
| 300 |
_ax, 513 p., [24] p. of plates : _bill. (some col.) ; _c29 cm. |
||
| 505 | 0 | _aSeeing the brain so we can save it: the evolution of magnetic resonance -- Imaging as a clinical tool -- Advances in the acute treatment and secondary prevention of stroke -- Preserving function in acute nervous system injury -- Slowing the progression of multiple sclerosis -- The emergence of neurosurgical approaches to the treatment of epilepsy -- The neurobiology of migraine and transformation of headache therapy -- Botulinum toxins: transformation of a toxin into a treatment -- Prospects for slowing the progression of Parkinson's disease -- Current neurosurgical treatments for Parkinson's disease: where did they come from? -- Treatable peripheral neuropathies: plasma exchange, intravenous immunoglobulin, and other emerging therapies -- Molecular pharmacology and the treatment of Tourette's syndrome and attention deficit-hyperactivity disorder -- Neuroscience, molecular medicine, and new approaches to the treatment of depression and anxiety -- Genomics, proteomics, and neurology -- Neuroprotection: where are we going? -- Prospects for gene therapy for central nervous system disease -- Therapeutics development for hereditary neurological diseases -- Inherited channelopathies of the CNS: lessons for clinical neurology -- Inherited channelopathies of muscle: implications for therapy -- Transcriptional channelopathies of the nervous system: new targets for molecular medicine -- New molecular targets for the treatment of neuropathic pain -- Therapeutic transfer and regeneration of neural progenitors or neurons in gray matter of the adult brain -- | |
| 505 | 0 | _aCellular plasticity of the adult human brain -- Harnessing endogenous stem cells for central nervous system repair -- Neuropathies-translating causes into treatments -- Inherited neuropathies -- Therapeutic potential of neurotrophic factors -- Promoting the regeneration of axons within the central nervous system -- Alzheimer's disease: clinical features, neuropathological and biochemical abnormalities, genetics, models, and experimental therapeutics -- Behavioral intervention and recovery from CNS damage -- What functional brain imaging will mean for neurology | |
| 650 | 2 |
_aNervous system diseases _xtherapy |
|
| 700 | 1 | _aWaxman, Stephen G. | |
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/description/els051/2004018953.html |
| 856 | 4 | 1 |
_3Table of contents _uhttp://www.loc.gov/catdir/toc/ecip0421/2004018953.html |
| 907 |
_a.b13760300 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWL140.F931 2005 9 |
||
| 914 | _avtls003330549 | ||
| 990 | _azr | ||
| 991 | _aProgram Psikologi Klinikal | ||
| 998 |
_ad _b2006-10-07 _cm _da _feng _gne _y0 _z.b13760300 |
||
| 999 |
_c374331 _d374331 |
||